The Sentinel-Record5h
FDA OKs painkiller designed to eliminate the risk of addiction
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
FDA approves first new non-opioid painkiller in decades, and it's from a MA company.
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
Post Register7h
FDA approves painkiller designed to eliminate risk of addiction associated with opioids
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
FDA approves Journavx, the first new painkiller in over two decades
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
WiscNews17h
FDA approves new painkiller that shows promise and challenges of opioid alternatives
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.
FDA approves painkiller said to thwart addiction
Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years ...
Becker's Hospital Review17h
FDA approves 1st-of-its-kind non-opioid pain medication
The FDA has approved suzetrigine, a new, non-opioid medication for adults with moderate to severe acute pain.
Morningstar15h
American Funds Washington Mutual R6
Nondividend payers, such as the fund's positions in Vertex Pharmaceuticals and Royal Caribbean Group, are capped at 5%. While the strategy has excluded alcohol or tobacco companies previously ...